Abbvie Endocrine Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBVIE ENDOCRINE, and what generic alternatives to ABBVIE ENDOCRINE drugs are available?
ABBVIE ENDOCRINE has seven approved drugs.
There are two US patents protecting ABBVIE ENDOCRINE drugs.
There are thirty-five patent family members on ABBVIE ENDOCRINE drugs in twenty-eight countries.
Summary for Abbvie Endocrine
International Patents: | 35 |
US Patents: | 2 |
Tradenames: | 4 |
Ingredients: | 2 |
NDAs: | 7 |
Drugs and US Patents for Abbvie Endocrine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-003 | Jun 17, 2011 | RX | Yes | Yes | 9,617,303 | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-003 | Jun 17, 2011 | RX | Yes | Yes | 8,921,326 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708-001 | Mar 7, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-002 | May 30, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-002 | Dec 14, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Abbvie Endocrine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-004 | Apr 16, 1993 | 4,954,298 | ⤷ Sign Up |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-001 | Dec 22, 1995 | 4,849,228 | ⤷ Sign Up |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708-001 | Mar 7, 1997 | 4,954,298 | ⤷ Sign Up |
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-003 | Apr 16, 1993 | 4,652,441 | ⤷ Sign Up |
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-008 | Aug 15, 2011 | 5,575,987 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Abbvie Endocrine Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 101563068 | ⤷ Sign Up |
Canada | 2671670 | ⤷ Sign Up |
Chile | 2007003658 | ⤷ Sign Up |
Australia | 2007335406 | ⤷ Sign Up |
Spain | 2791698 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.